MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

Monteris Medical

Corporate marketmedicalCurated record
monteris.com

Monteris Medical develops the NeuroBlate System, the only FDA-approved robotic laser interstitial thermal therapy (LITT) platform for minimally invasive brain surgery. The system uses MRI-guided robotics to navigate a laser probe through a small skull opening and ablate brain tumors, epileptogenic foci, and radiation necrosis in real time. In October 2025, Monteris partnered with Symphony Robotics to develop an AI-driven micro-robotic arm capable of operating within MRI bores and enabling non-linear laser probe trajectories. The system has been used in 9,000+ clinical cases across 130 US and Canadian health systems.

HeadquartersMinnetonka, US
Founded1999
Corporate funding$149M
Team51-200
Deployments3
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries E
FoundersNot listed
Regions servedNorth America
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

NeuroBlate System

  • Only FDA-approved LITT system with a robotic platform; 9,000+ clinical cases in 130+ health systems

    MRI-guided robotic laser ablation for brain tumors, epilepsy, and radiation necrosis

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2014-09-10Cleveland Clinichospital_neurosurgeryUSNot disclosedAnnouncement
2014-09-10UC San Diego Health Systemhospital_neurosurgeryUSNot disclosedAnnouncement
2014-09-10Yale New Haven Hospitalhospital_neurosurgeryUSNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordMadryn Asset ManagementTrinity Capital
TL

Company timeline

Milestones and announcements

2025-10-01Strategic collaboration with Symphony Robotics to launch AI-driven micro-robotic platform for laser ablation in the brainPR Newswire
2025-01-01Raised $28M Series E to advance NeuroBlate technology and expand market reachGSM Edtech
SC

Source ledger

12 unique public sources

01
Trinity Capital Inc. Provides $35 Million in Growth Capital to Monteris MedicalPR Newswire · retrieved 2026-07-05
02
Monteris Medical raises $28M Series E for robotic neurosurgery techGSM Edtech · retrieved 2026-07-05
03
SEC Form D: $13,700,000 sold of $13,700,000 offeringSEC EDGAR · retrieved 2026-07-05
04
SEC Form D: $9,000,000 sold of $30,000,000 offeringSEC EDGAR · retrieved 2026-07-05
05
SEC Form D: $2,500,000 sold of $6,136,275 offeringSEC EDGAR · retrieved 2026-07-05
06
SEC Form D: $10,682,010 sold of $17,157,115 offeringSEC EDGAR · retrieved 2026-07-05
07
SEC Form D: $26,579,945 sold of $26,579,945 offeringSEC EDGAR · retrieved 2026-07-05
08
SEC Form D: $6,830,567 sold of $10,000,000 offeringSEC EDGAR · retrieved 2026-07-05
09
SEC Form D: $16,900,851 sold of $25,050,000 offeringSEC EDGAR · retrieved 2026-07-05
10
Impressive Milestone for Monteris Medical's NeuroBlate SystemSurgical Robotics Technology · retrieved 2026-07-05
11
Monteris Medical Reaches Milestone For NeuroBlate SystemPR Newswire · retrieved 2026-07-05
12
Monteris Medical and Symphony Robotics Announce Strategic Collaboration to Launch AI-Driven Micro-Robotic PlatformPR Newswire · retrieved 2026-07-05